SCHEMBL18895956

SCHEMBL18895956

CC(=O)c1ccc2c(c1)/C(=C/CCN(C)CC(C)(C)C(C)(O)c1ccc(Cl)cc1)C1=CC=CNC1CO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12936669 0.72 CCR1 (0.49) —
SCHEMBL18895962 0.69 CCR1 (0.39) —
SCHEMBL18895955 0.69 CCR1 (0.38) —
SCHEMBL18896010 0.67 CCR1 (0.39) —
SCHEMBL18633826 0.67 CHRM2 (0.39) —
SCHEMBL16312652 0.66 — —
SCHEMBL18895959 0.66 CCR1 (0.34) —
SCHEMBL13824518 0.64 CHRM4 (0.33) —
SCHEMBL15478333 0.63 DRD2 (0.40) —
SCHEMBL14420175 0.63 CCR1 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback